Search results for: 'research area apoptosis bcl 2 family'
-
A3715 PF-04971729Summary: SGLT inhibitor
-
C5221 galacto-DapagliflozinSummary: potent inhibitor of human SGLT2
-
A4601 Empagliflozin (BI 10773)2 CitationSummary: SGLT-2 inhibitor for oral treatment of type 2 diabetes
-
A8333 Canagliflozin1 CitationTarget: SGLTSummary: SGLT2 inhibitor,potent and selective